Spotlight on Mobocertinib (TAK-788) in NSCLC with EGFR Exon 20 Insertion Mutations

The EGFR exon 20 insertion (EGFRex20ins) mutations are the third most common EGFR mutations seen in non-small cell lung cancer (NSCLC). More than 50 variants of EGFRex20ins mutations have been identified with A767_V769dupASV being the most common variant across multiple surveys. Treatment with curre...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shannon S, Zhu, Viola W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286072/
https://www.ncbi.nlm.nih.gov/pubmed/34285620
http://dx.doi.org/10.2147/LCTT.S307321

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8286072/
https://www.ncbi.nlm.nih.gov/pubmed/34285620
http://dx.doi.org/10.2147/LCTT.S307321

Ejemplares similares